Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:CANNOTCMKTS:DIGPOTCMKTS:NSAVOTCMKTS:PKPH On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCANNTREES$0.02+4.5%$0.03$0.01▼$0.08$2.32M-0.4189,681 shs55,795 shsDIGPHypha Labs$0.02-6.5%$0.03$0.01▼$0.07$2.82M0.4399,466 shs500 shsNSAVNet Savings Link$0.00$0.00▼$0.01N/A3.043.57 million shsN/APKPHPeak Pharmaceuticals$1.25+35.1%$2.00$0.52▼$9.12$490K0.549,053 shs802 shs7 Stocks to Buy And Hold ForeverEnter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCANNTREES0.00%+2.96%-21.72%-46.41%-66.88%DIGPHypha Labs-6.46%-18.00%-17.73%-15.17%+57.69%NSAVNet Savings Link0.00%0.00%0.00%-75.00%-98.61%PKPHPeak Pharmaceuticals0.00%+22.85%+31.77%-67.95%-43.18%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCANNTREESN/AN/AN/AN/AN/AN/AN/AN/ADIGPHypha LabsN/AN/AN/AN/AN/AN/AN/AN/ANSAVNet Savings LinkN/AN/AN/AN/AN/AN/AN/AN/APKPHPeak PharmaceuticalsN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCANNTREES 0.00N/AN/AN/ADIGPHypha Labs 0.00N/AN/AN/ANSAVNet Savings Link 0.00N/AN/AN/APKPHPeak Pharmaceuticals 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCANNTREES$13.66M0.17N/AN/A($0.01) per share-2.09DIGPHypha Labs$2.70M1.05N/AN/A($0.03) per share-0.82NSAVNet Savings LinkN/AN/AN/AN/AN/AN/APKPHPeak PharmaceuticalsN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCANNTREES-$7.08M-$0.02N/A∞N/AN/AN/AN/AN/ADIGPHypha Labs$250KN/A0.00∞N/AN/AN/A-35.56%N/ANSAVNet Savings LinkN/AN/A0.00N/AN/AN/AN/AN/AN/APKPHPeak Pharmaceuticals-$160KN/A0.00∞N/AN/AN/A-159.55%N/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCANNTREESN/AN/AN/AN/AN/ADIGPHypha LabsN/AN/AN/AN/AN/ANSAVNet Savings LinkN/AN/AN/AN/AN/APKPHPeak PharmaceuticalsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCANNTREESN/AN/AN/ADIGPHypha LabsN/A0.910.91NSAVNet Savings LinkN/AN/AN/APKPHPeak PharmaceuticalsN/A0.150.15Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCANNTREES11.28%DIGPHypha LabsN/ANSAVNet Savings LinkN/APKPHPeak PharmaceuticalsN/AInsider OwnershipCompanyInsider OwnershipCANNTREES45.00%DIGPHypha Labs10.80%NSAVNet Savings Link0.19%PKPHPeak Pharmaceuticals18.40%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCANNTREES80110.93 million61.01 millionNot OptionableDIGPHypha Labs20114.71 million102.32 millionNot OptionableNSAVNet Savings Link17.10 billion7.09 billionNot OptionablePKPHPeak Pharmaceuticals1392,000320,000Not OptionablePKPH, CANN, NSAV, and DIGP HeadlinesRecent News About These CompaniesAkari Therapeutics Merges with Peak Bio for GrowthNovember 9, 2024 | markets.businessinsider.comNetflix hit series Wednesday season 2 is a ‘cultural juggernaut’ that’s already breaking recordsNovember 4, 2024 | msn.comHow are pharmaceutical drug compounds separated?October 2, 2024 | news-medical.netNPiramal Pharma Solutions Plans $80M Expansion for Kentucky FacilityOctober 1, 2024 | genengnews.comGPhathom's Voquezna: A Breakthrough Drug Facing Marketing ChallengesSeptember 27, 2024 | seekingalpha.comThailand says mpox case recorded in traveller from AfricaAugust 22, 2024 | msn.comPharma stocks soar after WHO declares mpox public health emergencyAugust 20, 2024 | msn.comDaytime and early peak commissioningMay 2, 2024 | bbc.co.ukKingswood Capital Management Acquires PATCO ProductsApril 8, 2024 | preparedfoods.comPAkari Therapeutics Signs Merger-of-Equals with Peak BioMarch 5, 2024 | marketwatch.comAkari Therapeutics, Peak Bio Announces Agreement To Merge As Equals - Quick FactsMarch 5, 2024 | markets.businessinsider.comVote NowFebruary 19, 2024 | cbc.caBuy Rating Affirmed for Longboard Pharmaceuticals Amid Strong Bexicaserin Phase 2 Results and Blockbuster Revenue PotentialJanuary 9, 2024 | markets.businessinsider.comShares of Mankind Pharma Fall as Stakeholders Consider Reducing HoldingsDecember 12, 2023 | claytoncountyregister.comCHallowed Peak: Lunar FestivalOctober 31, 2023 | timeout.comTPeak Practice is axedJune 14, 2023 | dailymail.co.ukIs Peak Pharmaceuticals Inc (RMHI) Stock a Good Investment?June 6, 2023 | aaii.comAPeak Pharmaceuticals & Retrieve Medical Announce Signed Contract with Regional Medical CenterMay 31, 2023 | benzinga.comPeak Pharmaceuticals & Retrieve Medical Announce Signed Contract with Regional Medical CenterMay 31, 2023 | finance.yahoo.comMinnesota patients and providers navigate ‘historical peak’ of drug shortagesMay 5, 2023 | mprnews.orgMNew MarketBeat Followers Over TimeMedia Sentiment Over TimePKPH, CANN, NSAV, and DIGP Company DescriptionsTREES OTCMKTS:CANN$0.02 +0.00 (+4.50%) As of 07/3/2025 12:35 PM EasternTrees Corporation provides products and services to the regulated cannabis industry in the United States. The company operates through Retail and Cultivation segments. It operates a licensed 17,000 square foot light deprivation greenhouse cultivation facility; and retail dispensary store in Englewood, Colorado, as well as retail stores in Portland, Oregon. The company was formerly known as General Cannabis Corp. and changed its name to Trees Corporation in June 2022. Trees Corporation was incorporated in 2013 and is headquartered in Lakewood, Colorado.Hypha Labs OTCMKTS:DIGP$0.02 0.00 (-6.46%) As of 07/3/2025Hypha Labs, Inc., cultivates, produces, and sells psychedelic and functional mushroom in the United States. It has developed technology that quickly cultivates the mycelium root structures of psilocybin mushrooms and other functional mushroom's mycelium into a natural product. The company was incorporated in 2010 and is headquartered in Las Vegas, Nevada.Net Savings Link OTCMKTS:NSAVNet Savings Link, Inc. operates as a cryptocurrency, blockchain, and digital asset technology company. It holds interests in Cryptocurrency Trading Platform based on Artificial Intelligence (AI) and offers a range of trading services, such as portfolio management and price search function. This platform supports various cryptocurrency exchanges. The company is based in London, the United Kingdom.Peak Pharmaceuticals OTCMKTS:PKPH$1.25 +0.33 (+35.14%) As of 07/3/2025Peak Pharmaceuticals, Inc. manufactures and markets pharmaceutical level products containing phytocannabinoids, an abundant and pharmaceutically active component of industrial hemp for the prevention and alleviation of various conditions and diseases. The company was founded on December 18, 2007 and is headquartered in Scottsdale, AZ. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 06/30 - 07/04 The Apple Comeback Will Be Better Than the Setback Micron’s Big Q3 Drives Applied Materials’ Bullish Outlook Correction Equals Opportunity in Domino’s Pizza Stock Why Occidental's Price Dip Signals a Buying Opportunity Qualcomm’s Hold Rating Misses Strong Growth Story Rigetti Computing: Cantor's Bullish Call May Be Just the Start Insider Selling at NVIDIA Could Turn Into an Opportunity Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
